IFM Investors Pty Ltd Grows Position in Kenvue Inc. (NYSE:KVUE)

IFM Investors Pty Ltd increased its position in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 9.9% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 390,050 shares of the company's stock after purchasing an additional 35,112 shares during the quarter. IFM Investors Pty Ltd's holdings in Kenvue were worth $9,022,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. SRS Capital Advisors Inc. lifted its holdings in Kenvue by 67.4% in the fourth quarter. SRS Capital Advisors Inc. now owns 1,418 shares of the company's stock valued at $30,000 after acquiring an additional 571 shares during the period. Clarity Asset Management Inc. acquired a new position in Kenvue in the fourth quarter valued at approximately $45,000. SBI Securities Co. Ltd. acquired a new position in Kenvue in the fourth quarter valued at approximately $46,000. Continuum Advisory LLC lifted its holdings in Kenvue by 2,071.1% in the first quarter. Continuum Advisory LLC now owns 1,954 shares of the company's stock valued at $47,000 after acquiring an additional 1,864 shares during the period. Finally, Rossby Financial LCC acquired a new position in Kenvue in the first quarter valued at approximately $52,000. Institutional investors and hedge funds own 97.64% of the company's stock.

Analysts Set New Price Targets

A number of research analysts have issued reports on KVUE shares. Barclays boosted their price target on Kenvue from $22.00 to $23.00 and gave the company an "equal weight" rating in a report on Monday, May 12th. UBS Group boosted their price target on Kenvue from $24.00 to $25.00 and gave the company a "neutral" rating in a report on Friday, May 9th. Redburn Atlantic began coverage on Kenvue in a research report on Thursday, April 10th. They issued a "neutral" rating and a $23.50 price objective for the company. Citigroup restated a "neutral" rating on shares of Kenvue in a research report on Friday, June 13th. Finally, Evercore ISI began coverage on Kenvue in a research report on Monday, March 24th. They issued an "in-line" rating and a $25.00 price objective for the company. Seven analysts have rated the stock with a hold rating and five have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Kenvue has an average rating of "Hold" and an average target price of $25.33.

Kenvue Price Performance

Shares of KVUE traded up $0.12 during trading hours on Friday, hitting $21.02. 6,093,067 shares of the stock were exchanged, compared to its average volume of 16,141,426. Kenvue Inc. has a 12-month low of $17.67 and a 12-month high of $25.17. The company has a market cap of $40.32 billion, a price-to-earnings ratio of 38.21, a price-to-earnings-growth ratio of 3.27 and a beta of 0.83. The stock's 50-day moving average price is $22.61 and its two-hundred day moving average price is $22.32. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.60 and a current ratio of 0.86.

Kenvue (NYSE:KVUE - Get Free Report) last issued its earnings results on Thursday, May 8th. The company reported $0.24 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.23 by $0.01. Kenvue had a return on equity of 20.87% and a net margin of 6.90%. The business had revenue of $3.74 billion during the quarter, compared to the consensus estimate of $3.69 billion. During the same period last year, the company earned $0.28 EPS. The company's revenue for the quarter was down 3.9% on a year-over-year basis. Research analysts expect that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 28th. Stockholders of record on Wednesday, May 14th were issued a dividend of $0.205 per share. This represents a $0.82 dividend on an annualized basis and a dividend yield of 3.90%. The ex-dividend date was Wednesday, May 14th. Kenvue's dividend payout ratio is presently 149.09%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.